
Atovaquone
Composition
This formulation contains Atovaquone as active ingrediant.
Indications
Used to treat and prevent Pneumocystis jiroveci pneumonia (PCP), a serious lung infection caused by a fungus.
Side effects
Side effects may include nausea, vomiting, diarrhea, stomach pain, headache, and rash.
Precautions
Cautiously used in patients with liver disease, kidney disease
Contraindications
Contraindicated in patients with a known hypersensitivity to atovaquone
Dosage and administration
As directed by Physician
Countries
Worldwide
Available Forms
Tablets, suspension
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai